Opening their discussion on follicular lymphoma, experts Matthew Matasar, MD and Laurie Sehn, MD, reflect on its indolent nature as a subset of non-Hodgkin lymphoma.
Matthew J. Matasar, MD
Matthew J. Matasar, MD, is a hematologist/oncologist and chief, Division of Blood Disorders, at the Rutgers Cancer Institute, as well as a professor of medicine at Rutgers Robert Wood Johnson Medical School.
Articles by Matthew J. Matasar, MD
Matthew J. Matasar, MD, discusses the LOTIS-2 trial of loncastuximab tesirine in patients with relapsed/refractory diffuse large B-cell lymphoma.
Matthew J. Matasar, MD, discusses the current landscape of diffuse large B-cell lymphoma.
Matthew J. Matasar, MD, discusses how updates in the diffuse large B-cell lymphoma field have led to improved quality of life in patients.
Matt Matasar, MD, discusses treatment options in B-cell lymphomas.